Alambic Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-9,820
| Closed | -$1.6M | – | 459 |
|
|
2018
Q1 | $1.6M | Sell |
9,820
-14,100
| -59% | -$2.3M | 0.22% | 164 |
|
|
2017
Q4 | $3.59M | Sell |
23,920
-300
| -1% | -$45K | 0.43% | 78 |
|
|
2017
Q3 | $3.68M | Sell |
24,220
-50
| -0.2% | -$7.6K | 0.4% | 84 |
|
|
2017
Q2 | $3.13M | Buy |
24,270
+4,310
| +22% | +$555K | 0.38% | 73 |
|
|
2017
Q1 | $2.18M | Buy |
19,960
+2,270
| +13% | +$248K | 0.27% | 120 |
|
|
2016
Q4 | $1.3M | Buy |
17,690
+1,480
| +9% | +$109K | 0.23% | 157 |
|
|
2016
Q3 | $1.41M | Buy |
16,210
+4,175
| +35% | +$364K | 0.33% | 96 |
|
|
2016
Q2 | $1.04M | Buy |
12,035
+2,050
| +21% | +$176K | 0.26% | 134 |
|
|
2016
Q1 | $794K | Buy |
+9,985
| New | +$794K | 0.26% | 141 |
|